Evidence map›Paper›PMID 38528030›Full record

ArticleNature communications2024

Single drop cytometry onboard the International Space Station.

Daniel J Rea, Rachael S Miller, Brian E Crucian, Russell W Valentine, Samantha Cristoforetti, Samuel B Bearg, Zlatko Sipic, Jamie Cheng, Rebecca Yu, Kimesha M Calaway and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Daniel J Rea *DNA Medicine Institute (DMI), Bedford, MA, USA.ORCID http://orcid.org/0009-0004-9309-0689
Rachael S Miller *KBR, Houston, TX, USA.ORCID http://orcid.org/0009-0008-1689-3997
Brian E CrucianHuman Health and Performance Directorate, NASA Johnson Space Center, Houston, TX, USA.
Russell W ValentineZIN Technologies, Middleburg Heights, OH, USA.
Samantha CristoforettiEuropean Space Agency, Paris, France.
Samuel B BeargDNA Medicine Institute (DMI), Bedford, MA, USA.
Zlatko SipicDNA Medicine Institute (DMI), Bedford, MA, USA.
Jamie ChengDNA Medicine Institute (DMI), Bedford, MA, USA.
Rebecca YuDNA Medicine Institute (DMI), Bedford, MA, USA.
Kimesha M CalawayZIN Technologies, Middleburg Heights, OH, USA.
Dexter EamesGraylark, Cambridge, MA, USA.
Emily S NelsonNASA Glenn Research Center, Cleveland, OH, USA.
Beth E LewandowskiNASA Glenn Research Center, Cleveland, OH, USA.
Gail P PerusekNASA Glenn Research Center, Cleveland, OH, USA.
Eugene Y ChanDNA Medicine Institute (DMI), Bedford, MA, USA. echan@dnamedinstitute.com.ORCID http://orcid.org/0000-0003-1065-0050
DNA Medicine Institute (United States) · USGlenn Research Center · USZIN Technologies (United States) · USEngenderHealth · USEuropean Space Agency · FRJohnson Space Center · USKBR (United States) · US

Funding

National Aeronautics and Space Administration (NASA) 80NSSC18C0162
6 · The paper itself

Abstract

Real-time lab analysis is needed to support clinical decision making and research on human missions to the Moon and Mars. Powerful laboratory instruments, such as flow cytometers, are generally too cumbersome for spaceflight. Here, we show that scant test samples can be measured in microgravity, by a trained astronaut, using a miniature cytometry-based analyzer, the rHEALTH ONE, modified specifically for spaceflight. The base device addresses critical spaceflight requirements including minimal resource utilization and alignment-free optics for surviving rocket launch. To fully enable reduced gravity operation onboard the space station, we incorporated bubble-free fluidics, electromagnetic shielding, and gravity-independent sample introduction. We show microvolume flow cytometry from 10 μL sample drops, with data from five simultaneous channels using 10 μs bin intervals during each sample run, yielding an average of 72 million raw data points in approximately 2 min. We demonstrate the device measures each test sample repeatably, including correct identification of a sample that degraded in transit to the International Space Station. This approach can be utilized to further our understanding of spaceflight biology and provide immediate, actionable diagnostic information for management of astronaut health without the need for Earth-dependent analysis.

Indexed as

Space FlightWeightlessnessFlow CytometryHumansMoon

Identifiers

PMID38528030
PMCPMC10963801
OpenAlexW4393144639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.